ResMed Inc.
RMD Real Time Price USDRecent trades of RMD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in RMD holdings by institutional investors
Quarterly net insider trading by RMD's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$20,000 Oct 20, 2025 Issue: Medicare/Medicaid
-
$40,000 Oct 16, 2025 Issue: Health Issues
-
$60,000 Jul 21, 2025 Issue: Health Issues
-
$60,000 Apr 21, 2025 Issue: Health Issues
-
$60,000 Jan 21, 2025 Issue: Health Issues
-
$60,000 Oct 21, 2024 Issue: Health Issues
-
$40,000 Jul 22, 2024 Issue: Health Issues
-
$40,000 Jan 19, 2024 Issue: Medicare/Medicaid
-
$40,000 Oct 20, 2023 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Health Issues
-
$30,000 Nov 09, 2022 Issue: Health Issues
-
$50,000 Oct 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$20,000 Oct 19, 2022 Issue: Health Issues
-
$150,000 Aug 10, 2022 Issue: Health Issues
-
$180,000 Jul 28, 2022 Issue: Health Issues
-
$180,000 Jul 28, 2022 Issue: Health Issues
-
$30,000 Jul 20, 2022 Issue: Medicare/Medicaid
-
$40,000 Feb 09, 2022 Issue: Medicare/Medicaid Health Issues
-
$40,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$40,000 Apr 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$50,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$60,000 Oct 20, 2020 Issue: Health Issues Medicare/Medicaid
-
$40,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2020 Issue: Health Issues
-
$60,000 Jan 20, 2020 Issue: Health Issues
-
$60,000 Oct 20, 2019 Issue: Health Issues
-
$140,000 Jul 22, 2019 Issue: Health Issues
-
$70,000 Apr 22, 2019 Issue: Health Issues
-
$60,000 Jan 22, 2019 Issue: Health Issues
-
$70,000 Oct 22, 2018 Issue: Health Issues
-
$70,000 Jul 20, 2018 Issue: Health Issues
-
$80,000 Apr 19, 2018 Issue: Health Issues
-
$20,000 Jan 22, 2018 Issue: Medicare/Medicaid
-
$60,000 Jan 18, 2018 Issue: Health Issues
-
$10,000 Oct 19, 2017 Issue: Medicare/Medicaid
-
$60,000 Oct 16, 2017 Issue: Health Issues
-
$10,000 Jul 28, 2017 Issue: Medicare/Medicaid
-
$60,000 Jul 20, 2017 Issue: Health Issues
-
$60,000 Apr 19, 2017 Issue: Health Issues
-
$20,000 Apr 19, 2016 Issue: Health Issues
-
$10,000 Oct 08, 2009 Issue: Medicare/Medicaid
-
$10,000 Jul 07, 2009 Issue: Medicare/Medicaid
-
$10,000 Apr 14, 2009 Issue: Medicare/Medicaid
-
$10,000 Jan 19, 2009 Issue: Medicare/Medicaid
-
$10,000 Oct 13, 2008 Issue: Medicare/Medicaid
-
$15,000 Jul 15, 2008 Issue: Medicare/Medicaid
-
$15,000 Apr 14, 2008 Issue: Medicare/Medicaid
-
$80,000 Feb 13, 2006 Issue: Health Issues
-
$120,000 Aug 12, 2005 Issue: Health Issues
-
$100,000 Feb 17, 2005 Issue: Health Issues
RMD Estimated quarterly lobbying spending
RMD Revenue by Segment or Geography
New RMD patent grants
-
Patent Title: Display screen or portion thereof with animated graphical user interface Oct. 07, 2025
-
Patent Title: Display screen or portion thereof with animated graphical user interface Oct. 07, 2025
-
Patent Title: Display screen with graphical user interface Aug. 12, 2025
-
Patent Title: Display screen or portion thereof with graphical user interface Aug. 05, 2025
-
Patent Title: Display screen or portion thereof with graphical user interface Jun. 10, 2025
-
Patent Title: Display screen or portion thereof with graphical user interface Jun. 03, 2025
-
Patent Title: Display screen or portion thereof with animated graphical user interface Jul. 16, 2024
-
Patent Title: Display screen or portion thereof with transitional graphical user interface Jul. 09, 2024
-
Patent Title: Display screen or portion thereof with a graphical user interface Dec. 26, 2023
-
Patent Title: Connector for a respiratory mask and a respiratory mask Jun. 19, 2018
-
Patent Title: Gel cushion pad for mask Jun. 19, 2018
-
Patent Title: Electrical heater with particular application to humidification and fluid warming Jun. 12, 2018
-
Patent Title: Mask system Jun. 12, 2018
-
Patent Title: Pap system Jun. 12, 2018
-
Patent Title: Humidification arrangement for a respiratory apparatus Jun. 05, 2018
-
Patent Title: Interface including a foam cushioning element Jun. 05, 2018
-
Patent Title: Elbow assembly May. 29, 2018
-
Patent Title: Respiratory mask May. 29, 2018
-
Patent Title: Apparatus for supplying a breathing gas May. 29, 2018
-
Patent Title: Elastic headgear May. 22, 2018
-
Patent Title: Method and apparatus for providing ventilatory assistance May. 22, 2018
-
Patent Title: Removable and/or replaceable humidifier May. 15, 2018
-
Patent Title: Forehead support for a patient interface May. 15, 2018
-
Patent Title: Method and apparatus for resolving upper airway obstruction, resistance or instability May. 15, 2018
-
Patent Title: Mask assembly and headgear May. 08, 2018
-
Patent Title: Mask system with snap-fit shroud May. 08, 2018
-
Patent Title: Respiratory mask assembly May. 08, 2018
-
Patent Title: Mask system with snap-fit shroud Apr. 24, 2018
-
Patent Title: Method and apparatus for humidification of breathable gas by condensation and/or dehumidification Apr. 17, 2018
-
Patent Title: Nasal prongs for mask system Apr. 17, 2018
-
Patent Title: Mask with removable headgear connector Apr. 10, 2018
-
Patent Title: Delivery of respiratory therapy with foam interface Apr. 10, 2018
-
Patent Title: Breathing assistance device with linear actuated gas regulating valve Mar. 20, 2018
-
Patent Title: Cuff for air delivery conduit Feb. 27, 2018
-
Patent Title: Mask pressure regulation in cpap treatment and assisted respiration by dynamic control of mask vent flow Feb. 27, 2018
-
Patent Title: Mask and headgear connector Feb. 27, 2018
-
Patent Title: Pad for a mask Feb. 27, 2018
-
Patent Title: Compliant coupler or adaptor Feb. 20, 2018
-
Patent Title: Cushion for mask system Feb. 20, 2018
-
Patent Title: Nasal assembly Feb. 20, 2018
-
Patent Title: Mask system Feb. 20, 2018
-
Patent Title: Patient interface Feb. 13, 2018
-
Patent Title: Method and apparatus for detecting cardiac signals Feb. 13, 2018
-
Patent Title: Headgear for masks Jan. 30, 2018
-
Patent Title: Swivel elbow for mask assembly Jan. 30, 2018
-
Patent Title: Pressure control in respiratory treatment apparatus Jan. 30, 2018
-
Patent Title: Humidifier reservoir Jan. 09, 2018
-
Patent Title: Humidifier for respiratory apparatus Jan. 02, 2018
-
Patent Title: Tube retainer Jan. 26, 2010
-
Patent Title: Forehead pad Jan. 12, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded to RMD from public contracts
Recent insights relating to RMD
Recent picks made for RMD stock on CNBC
ETFs with the largest estimated holdings in RMD
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $RMD stock a Buy, Sell, or Hold?
- What is the price target for $RMD stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $RMD stock?
- Who owns the most shares of $RMD stock?
- What funds own $RMD stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RMD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
- Address San Diego, CA
- Market Cap 36.8 billion
- Employees 10,600
- Industrial Classification Surgical & Medical Instruments & Apparatus